Business description
With a focus on transformative medicines in oncology, rare disease and neuroscience, our vision is to be a leading global mid-size biopharmaceutical company. With the right combination of size and agility, we continue to push ourselves as a business and as individuals to deliver positive change.
Management board & Supervisory board
CEO |
David Loew |
Management board |
Yan Moore M.D., Aymeric Le Chatelier, Aidan Murphy Ph.D., Craig Marks, Francois Garnier, Gwenan White, Regis Mulot, Dominique Bery, Alexander McEwan |
Supervisory board |
- |
Company data
Name: |
Ipsen SA |
Address: |
65, quai Georges Gorse,65, quai Georges Gorse Boulogne-Billancourt 92100 |
Phone: |
+33 1 58 33 50 00 |
Fax: |
- |
E-mail: |
-
|
Internet: |
https://www.ipsen.com |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
12-31 |
Free Float: |
41.52% |
IPO date: |
2005-12-01 |
Investor relations
Name: |
Craig Marks |
IR phone: |
+44 7584 349 193 |
IR Fax: |
- |
IR e-mail: |
-
|